Metabolic syndrome as a predictor of non-dipping hypertension

Tohoku Journal of Experimental Medicine

Volumn 210, Issue 1, 2006, Pages 57-66

  Tartan, Zeynep ^a,b   Uyarel, Huseyin ^a   Kasikcioglu, Hulya ^a   Alper, Ahmet Taha ^a   Ozay, Batuhan ^a   Bilsel, Tuba ^a   Gul, Mehmet ^a   Ozturk, Recep ^a   Cam, Nese ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Circadian blood pressure variation; Hypertension; Metabolic syndrome adult treatment panel III; Metabolic syndrome score; Non dipping pattern

Indexed keywords

ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; FREQUENCY ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NIGHT; PATHOPHYSIOLOGY; PREDICTION; RISK ASSESSMENT; SCORING SYSTEM; SMOKING; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 33748616253     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.210.57     Document Type: Article

References (23)

1. Alberti, K.G. & Zimmet, P.Z. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med., 15, 539-553.
2. Banskota, N.K., Taub, R., Zellner, K., Olsen, P. & King, G. (1989) Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells in insulin and IGF-1. Diabetes, 38, 123-129.
3. Bianchi, S., Bigazzi, R., Baldari, G., Sgherri, G. & Campese, V.M. (1994) Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am. J. Hypertens., 7, 23-29.
4. Cuspidi, C., Meani, S., Fusi, V., Severgnini, B., Valerio, C., Catini, E., Leonetti, G., Magrini, F. & Zanchetti, A. (2004a) Metabolic syndrome and target organ damage in untreated essential hypertensives. J. Hypertens., 22, 1991-1998.
5. Cuspidi, C., Meani, F., Salerno, M., Valerio, C., Fusi, V., Severgnini, B., Lonati, L., Magrini, F. & Zanchetti, A. (2004b) Cardiovascular target organ damage in essential hypertensives with or without reproducible nocturnal fall in blood pressure. J. Hypertens., 22, 273-280.
6. Cuspidi, C., Meani, S., Fusi, V., Severgini, F., Valerio, C., Catini, E., Sala, C., Magnaghi, F. & Zanchetti, A. (2004c) Is the nocturnal fall in blood pressure reduced in essential hypertensive patients with metabolic syndrome? Blood Press., 13, 230-235.
7. Della Mea, P., Lupia, M., Bandolin, V., Guzzon, S., Sonino, N., Vettor, R. & Fallo, F. (2005) Adiponectin, insulin resistance, and left ventricular structure in dipper and nondipper essential hypertensive patients. Am. J. Hypertens., 18, 30-35.
8. Foss, H.C., Vestbo, E., Froland, A., Gjessing, H.J., Mogensen, C.E. & Damsgaard, E.M. (2000) Normal blood pressure and preserved variation in offspring of type 2 diabetic patients characterized by features of the metabolic syndrome. Diabetes Care, 23, 283-289.
9. Haffner, S.M., Fong, D., Hazuda, H.P., Pugh, J.A. & Patterson, J.K. (1998) Hyperinsulinemia, upper body adiposity and cardiovascular risk factors in non-diabetics. Metabolism, 37, 338-345.
10. Higashi, Y., Nakagawa, K., Kimura, M., Noma, K., Hara, K., Sasaki, S., Goto, C., Oshima, T., Chayama, K. & Yoshizumi, M. (2002) Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J. Am. Coll. Cardiol., 40, 2039-2043.
11. Hommel, E., Mathiesen, E.R., Giese, J., Nieisen, M.D., Schutten, H. & Parving, H.H. (1989) On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy. Scand J. Clin. Lab. Invest., 49, 537-544.
12. Kario, K., Pickering, T.G., Matsuo, T., Hoshide, S., Schwartz, J.E. & Shimada, K. (2001) stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension, 38, 852-857.
13. Macchia, A., Levantesi, G., Borrelli, G.,Franzosi, M.G., Maggioni, A.P., Marfisi, R.M., Scarano, M. & Tavazzi, L. (2006) A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. Am. Heart J., 151, 754e7-754e17.
14. Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A. & Fuchs, Z. (1985) Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J. Clin. Invest., 75, 809-817.
15. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program,(NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143-3421.
16. Perk, G., Mekler, J., Ben Ishay, D. & Bursztyn, M. (2002) Non-dipping in diabetic patients: insights from the siesta. J. Hum. Hypertens., 16,435-438.
17. Reaven, G.M. (1998) Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
18. Staessen, J.A., Thijs, L., Fagard, R., O'Brian, E.T., Clement, D., de Leeuw, P.W., Mancia, G., Nachev, C., Palatini, P., Tuomilehto, J. & Webster, J. (1999) Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with with systolic hypertension. JAMA, 282, 539-546.
19. Sherwood, A., Steffen, P.R., Blumenthal, J.A., Kuhn, C. & Hinderliter, A.L. (2002) Night time blood pressure dipping: the role of the sympathetic nervous system. Am. J. Hypertens., 15, 111-118.
20. Swislocki, A.L.M., Hoffman, B.B. & Reaven, G.M. (1989) Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am. J. Hypertens., 2, 419-423.
21. Takakuwa, H., Ise, T., Kato, T., Izumiya, Y., Shimizu, K., Yokoyama, H. & Kobayashi, K.I. (2001) Diurnal variation of hemodynamic indices in non-dipper hypertensive patients. Hypertens. Res., 24, 195-203.
22. Weber, M.A. (1987) Cardiovascular outcomes of treating high blood pressure. Am. Heart J., 114, 964-971.
23. Weber, M.A. (1989) Antihypertensive treatment: considerations beyond blood pressure control. Circulation, 80, Suppl. IV, IV120-IV127.